nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—ALB—Levothyroxine—hypothyroidism	0.144	0.304	CbGbCtD
Pethidine—ALB—Liothyronine—hypothyroidism	0.144	0.304	CbGbCtD
Pethidine—ALB—Liotrix—hypothyroidism	0.141	0.297	CbGbCtD
Pethidine—CYP3A4—Levothyroxine—hypothyroidism	0.0452	0.0953	CbGbCtD
Pethidine—GRIN2C—nerve—hypothyroidism	0.0114	0.105	CbGeAlD
Pethidine—Muscle twitching—Liothyronine—hypothyroidism	0.0101	0.0469	CcSEcCtD
Pethidine—GRIN2B—nerve—hypothyroidism	0.00903	0.083	CbGeAlD
Pethidine—Phlebitis—Liothyronine—hypothyroidism	0.00837	0.0388	CcSEcCtD
Pethidine—GRIN2A—nerve—hypothyroidism	0.0079	0.0725	CbGeAlD
Pethidine—OPRM1—nerve—hypothyroidism	0.0048	0.0441	CbGeAlD
Pethidine—CYP2C19—urine—hypothyroidism	0.00479	0.044	CbGeAlD
Pethidine—Coma—Dextrothyroxine—hypothyroidism	0.00446	0.0207	CcSEcCtD
Pethidine—Coma—Levothyroxine—hypothyroidism	0.00446	0.0207	CcSEcCtD
Pethidine—GRIN1—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.00443	0.022	CbGpPWpGaD
Pethidine—GRIN1—CREB phosphorylation through the activation of CaMKII—NEFL—hypothyroidism	0.00443	0.022	CbGpPWpGaD
Pethidine—GRIN2C—adrenal cortex—hypothyroidism	0.00439	0.0403	CbGeAlD
Pethidine—SLC6A3—nerve—hypothyroidism	0.00436	0.04	CbGeAlD
Pethidine—GRIN2C—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.00434	0.0216	CbGpPWpGaD
Pethidine—GRIN2B—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.00432	0.0215	CbGpPWpGaD
Pethidine—GRIN2B—CREB phosphorylation through the activation of CaMKII—NEFL—hypothyroidism	0.00432	0.0215	CbGpPWpGaD
Pethidine—Hyperkinesia—Levothyroxine—hypothyroidism	0.00425	0.0197	CcSEcCtD
Pethidine—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00425	0.0197	CcSEcCtD
Pethidine—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—NEFL—hypothyroidism	0.00405	0.0202	CbGpPWpGaD
Pethidine—GRIN2D—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.00403	0.0201	CbGpPWpGaD
Pethidine—Disorientation—Dextrothyroxine—hypothyroidism	0.00396	0.0184	CcSEcCtD
Pethidine—Disorientation—Levothyroxine—hypothyroidism	0.00396	0.0184	CcSEcCtD
Pethidine—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—NEFL—hypothyroidism	0.00395	0.0196	CbGpPWpGaD
Pethidine—Hypertension—Liothyronine—hypothyroidism	0.00375	0.0174	CcSEcCtD
Pethidine—Muscle twitching—Liotrix—hypothyroidism	0.00365	0.017	CcSEcCtD
Pethidine—GRIN2C—Post NMDA receptor activation events—NEFL—hypothyroidism	0.00357	0.0178	CbGpPWpGaD
Pethidine—SLC6A2—nerve—hypothyroidism	0.00351	0.0323	CbGeAlD
Pethidine—Affect lability—Levothyroxine—hypothyroidism	0.00348	0.0162	CcSEcCtD
Pethidine—Affect lability—Dextrothyroxine—hypothyroidism	0.00348	0.0162	CcSEcCtD
Pethidine—Tachycardia—Liothyronine—hypothyroidism	0.00346	0.016	CcSEcCtD
Pethidine—Irritability—Levothyroxine—hypothyroidism	0.00338	0.0157	CcSEcCtD
Pethidine—Irritability—Dextrothyroxine—hypothyroidism	0.00338	0.0157	CcSEcCtD
Pethidine—Cardiac arrest—Levothyroxine—hypothyroidism	0.00337	0.0156	CcSEcCtD
Pethidine—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00337	0.0156	CcSEcCtD
Pethidine—Mood swings—Dextrothyroxine—hypothyroidism	0.00335	0.0156	CcSEcCtD
Pethidine—Mood swings—Levothyroxine—hypothyroidism	0.00335	0.0156	CcSEcCtD
Pethidine—GRIN2D—Post NMDA receptor activation events—NEFL—hypothyroidism	0.00332	0.0165	CbGpPWpGaD
Pethidine—GRIN2A—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.00331	0.0165	CbGpPWpGaD
Pethidine—Hypotension—Liothyronine—hypothyroidism	0.00331	0.0154	CcSEcCtD
Pethidine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00329	0.0164	CbGpPWpGaD
Pethidine—Coma—Liotrix—hypothyroidism	0.00328	0.0152	CcSEcCtD
Pethidine—Lightheadedness—Liotrix—hypothyroidism	0.00321	0.0149	CcSEcCtD
Pethidine—Hyperkinesia—Liotrix—hypothyroidism	0.00313	0.0145	CcSEcCtD
Pethidine—SLC6A4—Monoamine Transport—SLC5A7—hypothyroidism	0.00311	0.0155	CbGpPWpGaD
Pethidine—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00306	0.0152	CbGpPWpGaD
Pethidine—GRIN2C—thyroid gland—hypothyroidism	0.00306	0.0281	CbGeAlD
Pethidine—Phlebitis—Liotrix—hypothyroidism	0.00302	0.014	CcSEcCtD
Pethidine—GRIN2A—heart—hypothyroidism	0.00293	0.0269	CbGeAlD
Pethidine—Disorientation—Liotrix—hypothyroidism	0.00291	0.0135	CcSEcCtD
Pethidine—GRIN1—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.00289	0.0144	CbGpPWpGaD
Pethidine—CYP3A4—urine—hypothyroidism	0.00283	0.026	CbGeAlD
Pethidine—GRIN2B—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.00282	0.014	CbGpPWpGaD
Pethidine—SLC6A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00281	0.014	CbGpPWpGaD
Pethidine—CYP2D6—urine—hypothyroidism	0.00279	0.0256	CbGeAlD
Pethidine—GRIN2A—Post NMDA receptor activation events—NEFL—hypothyroidism	0.00273	0.0136	CbGpPWpGaD
Pethidine—SLC6A2—Monoamine Transport—SLC5A7—hypothyroidism	0.00267	0.0133	CbGpPWpGaD
Pethidine—GRIN2C—testis—hypothyroidism	0.00262	0.0241	CbGeAlD
Pethidine—Sweating—Levothyroxine—hypothyroidism	0.00261	0.0121	CcSEcCtD
Pethidine—Sweating—Dextrothyroxine—hypothyroidism	0.00261	0.0121	CcSEcCtD
Pethidine—Affect lability—Liotrix—hypothyroidism	0.00256	0.0119	CcSEcCtD
Pethidine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00251	0.0125	CbGpPWpGaD
Pethidine—SLC6A3—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00249	0.0124	CbGpPWpGaD
Pethidine—Irritability—Liotrix—hypothyroidism	0.00248	0.0115	CcSEcCtD
Pethidine—Cardiac arrest—Liotrix—hypothyroidism	0.00248	0.0115	CcSEcCtD
Pethidine—Mood swings—Liotrix—hypothyroidism	0.00247	0.0114	CcSEcCtD
Pethidine—GRIN2D—testis—hypothyroidism	0.00243	0.0224	CbGeAlD
Pethidine—GRIN2C—cerebellum—hypothyroidism	0.00242	0.0222	CbGeAlD
Pethidine—GRIN1—Post NMDA receptor activation events—NEFL—hypothyroidism	0.00238	0.0118	CbGpPWpGaD
Pethidine—SLC6A3—Monoamine Transport—SLC5A7—hypothyroidism	0.00237	0.0118	CbGpPWpGaD
Pethidine—GRIN2B—Post NMDA receptor activation events—NEFL—hypothyroidism	0.00232	0.0115	CbGpPWpGaD
Pethidine—Flushing—Dextrothyroxine—hypothyroidism	0.00227	0.0105	CcSEcCtD
Pethidine—Flushing—Levothyroxine—hypothyroidism	0.00227	0.0105	CcSEcCtD
Pethidine—GRIN2D—cerebellum—hypothyroidism	0.00225	0.0207	CbGeAlD
Pethidine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00219	0.0109	CbGpPWpGaD
Pethidine—GRIN2A—adrenal gland—hypothyroidism	0.00219	0.0201	CbGeAlD
Pethidine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00213	0.0106	CbGpPWpGaD
Pethidine—GRIN1—cerebellum—hypothyroidism	0.002	0.0184	CbGeAlD
Pethidine—Tremor—Dextrothyroxine—hypothyroidism	0.002	0.00927	CcSEcCtD
Pethidine—Tremor—Levothyroxine—hypothyroidism	0.002	0.00927	CcSEcCtD
Pethidine—Agitation—Dextrothyroxine—hypothyroidism	0.00196	0.00909	CcSEcCtD
Pethidine—Agitation—Levothyroxine—hypothyroidism	0.00196	0.00909	CcSEcCtD
Pethidine—Sweating—Liotrix—hypothyroidism	0.00192	0.00893	CcSEcCtD
Pethidine—GRIN2B—cerebellum—hypothyroidism	0.00191	0.0176	CbGeAlD
Pethidine—Palpitations—Dextrothyroxine—hypothyroidism	0.00188	0.00874	CcSEcCtD
Pethidine—Palpitations—Levothyroxine—hypothyroidism	0.00188	0.00874	CcSEcCtD
Pethidine—Convulsion—Levothyroxine—hypothyroidism	0.00185	0.00857	CcSEcCtD
Pethidine—Convulsion—Dextrothyroxine—hypothyroidism	0.00185	0.00857	CcSEcCtD
Pethidine—GRIN2A—testis—hypothyroidism	0.00181	0.0166	CbGeAlD
Pethidine—Anxiety—Dextrothyroxine—hypothyroidism	0.00181	0.0084	CcSEcCtD
Pethidine—Anxiety—Levothyroxine—hypothyroidism	0.00181	0.0084	CcSEcCtD
Pethidine—Confusional state—Dextrothyroxine—hypothyroidism	0.00175	0.00814	CcSEcCtD
Pethidine—Confusional state—Levothyroxine—hypothyroidism	0.00175	0.00814	CcSEcCtD
Pethidine—Shock—Levothyroxine—hypothyroidism	0.00171	0.00795	CcSEcCtD
Pethidine—Shock—Dextrothyroxine—hypothyroidism	0.00171	0.00795	CcSEcCtD
Pethidine—Tachycardia—Dextrothyroxine—hypothyroidism	0.0017	0.00788	CcSEcCtD
Pethidine—Tachycardia—Levothyroxine—hypothyroidism	0.0017	0.00788	CcSEcCtD
Pethidine—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00168	0.00781	CcSEcCtD
Pethidine—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00168	0.00781	CcSEcCtD
Pethidine—Flushing—Liotrix—hypothyroidism	0.00167	0.00776	CcSEcCtD
Pethidine—GRIN2A—cerebellum—hypothyroidism	0.00167	0.0153	CbGeAlD
Pethidine—Insomnia—Levothyroxine—hypothyroidism	0.00157	0.0073	CcSEcCtD
Pethidine—Insomnia—Dextrothyroxine—hypothyroidism	0.00157	0.0073	CcSEcCtD
Pethidine—ALB—heart—hypothyroidism	0.00153	0.014	CbGeAlD
Pethidine—SLC6A4—Synaptic Vesicle Pathway—CLTC—hypothyroidism	0.00148	0.00738	CbGpPWpGaD
Pethidine—Tremor—Liotrix—hypothyroidism	0.00147	0.00682	CcSEcCtD
Pethidine—Agitation—Liotrix—hypothyroidism	0.00144	0.00669	CcSEcCtD
Pethidine—GRIN2C—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00144	0.00714	CbGpPWpGaD
Pethidine—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00143	0.00665	CcSEcCtD
Pethidine—Feeling abnormal—Levothyroxine—hypothyroidism	0.00143	0.00665	CcSEcCtD
Pethidine—GRIN1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00143	0.00712	CbGpPWpGaD
Pethidine—OPRK1—cerebellum—hypothyroidism	0.00143	0.0131	CbGeAlD
Pethidine—Syncope—Liotrix—hypothyroidism	0.00141	0.00653	CcSEcCtD
Pethidine—Palpitations—Liotrix—hypothyroidism	0.00139	0.00643	CcSEcCtD
Pethidine—Urticaria—Levothyroxine—hypothyroidism	0.00138	0.00642	CcSEcCtD
Pethidine—Urticaria—Dextrothyroxine—hypothyroidism	0.00138	0.00642	CcSEcCtD
Pethidine—Loss of consciousness—Liotrix—hypothyroidism	0.00138	0.0064	CcSEcCtD
Pethidine—Convulsion—Liotrix—hypothyroidism	0.00136	0.00631	CcSEcCtD
Pethidine—Hypertension—Liotrix—hypothyroidism	0.00135	0.00628	CcSEcCtD
Pethidine—GRIN2D—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00134	0.00664	CbGpPWpGaD
Pethidine—Anxiety—Liotrix—hypothyroidism	0.00133	0.00618	CcSEcCtD
Pethidine—OPRM1—blood—hypothyroidism	0.00133	0.0122	CbGeAlD
Pethidine—GRIN2B—ErbB4 signaling events—PRL—hypothyroidism	0.00133	0.0066	CbGpPWpGaD
Pethidine—ORM1—blood—hypothyroidism	0.0013	0.0119	CbGeAlD
Pethidine—Confusional state—Liotrix—hypothyroidism	0.00129	0.00599	CcSEcCtD
Pethidine—Anaphylactic shock—Liotrix—hypothyroidism	0.00128	0.00594	CcSEcCtD
Pethidine—Oedema—Liotrix—hypothyroidism	0.00128	0.00594	CcSEcCtD
Pethidine—Shock—Liotrix—hypothyroidism	0.00126	0.00584	CcSEcCtD
Pethidine—Tachycardia—Liotrix—hypothyroidism	0.00125	0.0058	CcSEcCtD
Pethidine—Asthenia—Dextrothyroxine—hypothyroidism	0.00125	0.00579	CcSEcCtD
Pethidine—Asthenia—Levothyroxine—hypothyroidism	0.00125	0.00579	CcSEcCtD
Pethidine—Hyperhidrosis—Liotrix—hypothyroidism	0.00124	0.00574	CcSEcCtD
Pethidine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00123	0.00612	CbGpPWpGaD
Pethidine—Pruritus—Dextrothyroxine—hypothyroidism	0.00123	0.00571	CcSEcCtD
Pethidine—Pruritus—Levothyroxine—hypothyroidism	0.00123	0.00571	CcSEcCtD
Pethidine—Anorexia—Liotrix—hypothyroidism	0.00122	0.00566	CcSEcCtD
Pethidine—GRIN1—EPH-Ephrin signaling—CLTC—hypothyroidism	0.00121	0.00603	CbGpPWpGaD
Pethidine—Hypotension—Liotrix—hypothyroidism	0.0012	0.00555	CcSEcCtD
Pethidine—GRIN2B—EPH-Ephrin signaling—CLTC—hypothyroidism	0.00118	0.00588	CbGpPWpGaD
Pethidine—Insomnia—Liotrix—hypothyroidism	0.00116	0.00537	CcSEcCtD
Pethidine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00114	0.00569	CbGpPWpGaD
Pethidine—ALB—adrenal gland—hypothyroidism	0.00114	0.0105	CbGeAlD
Pethidine—SLC6A2—gonad—hypothyroidism	0.00112	0.0103	CbGeAlD
Pethidine—Decreased appetite—Liotrix—hypothyroidism	0.00111	0.00516	CcSEcCtD
Pethidine—SLC6A4—blood—hypothyroidism	0.00111	0.0102	CbGeAlD
Pethidine—Vomiting—Dextrothyroxine—hypothyroidism	0.00111	0.00513	CcSEcCtD
Pethidine—Vomiting—Levothyroxine—hypothyroidism	0.00111	0.00513	CcSEcCtD
Pethidine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.0011	0.00547	CbGpPWpGaD
Pethidine—GRIN2C—Neuronal System—SLC5A7—hypothyroidism	0.0011	0.00547	CbGpPWpGaD
Pethidine—OPRM1—testis—hypothyroidism	0.0011	0.0101	CbGeAlD
Pethidine—Rash—Levothyroxine—hypothyroidism	0.0011	0.00509	CcSEcCtD
Pethidine—Rash—Dextrothyroxine—hypothyroidism	0.0011	0.00509	CcSEcCtD
Pethidine—GRIN2A—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.0011	0.00545	CbGpPWpGaD
Pethidine—Dermatitis—Dextrothyroxine—hypothyroidism	0.0011	0.00509	CcSEcCtD
Pethidine—Dermatitis—Levothyroxine—hypothyroidism	0.0011	0.00509	CcSEcCtD
Pethidine—Constipation—Liotrix—hypothyroidism	0.00109	0.00508	CcSEcCtD
Pethidine—Headache—Levothyroxine—hypothyroidism	0.00109	0.00506	CcSEcCtD
Pethidine—Headache—Dextrothyroxine—hypothyroidism	0.00109	0.00506	CcSEcCtD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00107	0.00534	CbGpPWpGaD
Pethidine—Feeling abnormal—Liotrix—hypothyroidism	0.00105	0.0049	CcSEcCtD
Pethidine—Nausea—Dextrothyroxine—hypothyroidism	0.00103	0.0048	CcSEcCtD
Pethidine—Nausea—Levothyroxine—hypothyroidism	0.00103	0.0048	CcSEcCtD
Pethidine—GRIN2D—Neuronal System—SLC5A7—hypothyroidism	0.00102	0.00509	CbGpPWpGaD
Pethidine—Urticaria—Liotrix—hypothyroidism	0.00102	0.00472	CcSEcCtD
Pethidine—ORM1—liver—hypothyroidism	0.00102	0.00932	CbGeAlD
Pethidine—SLC6A3—testis—hypothyroidism	0.000998	0.00917	CbGeAlD
Pethidine—CYP2B6—adrenal cortex—hypothyroidism	0.000994	0.00913	CbGeAlD
Pethidine—ALB—Transport of organic anions—AVP—hypothyroidism	0.000993	0.00494	CbGpPWpGaD
Pethidine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000975	0.00485	CbGpPWpGaD
Pethidine—SLC6A2—adrenal gland—hypothyroidism	0.000974	0.00894	CbGeAlD
Pethidine—CYP2B6—heart—hypothyroidism	0.000961	0.00883	CbGeAlD
Pethidine—GRIN1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000956	0.00476	CbGpPWpGaD
Pethidine—Hypersensitivity—Liotrix—hypothyroidism	0.000943	0.00438	CcSEcCtD
Pethidine—ALB—testis—hypothyroidism	0.000941	0.00865	CbGeAlD
Pethidine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00094	0.00468	CbGpPWpGaD
Pethidine—GRIN2B—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000932	0.00464	CbGpPWpGaD
Pethidine—GRIN2C—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000925	0.0046	CbGpPWpGaD
Pethidine—SLC6A4—NRF2 pathway—SLC5A7—hypothyroidism	0.000923	0.00459	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000922	0.00459	CbGpPWpGaD
Pethidine—SLC6A3—cerebellum—hypothyroidism	0.000922	0.00847	CbGeAlD
Pethidine—Asthenia—Liotrix—hypothyroidism	0.000918	0.00426	CcSEcCtD
Pethidine—CYP2C19—blood—hypothyroidism	0.000916	0.00842	CbGeAlD
Pethidine—CYP2B6—cardiovascular system—hypothyroidism	0.000907	0.00833	CbGeAlD
Pethidine—Pruritus—Liotrix—hypothyroidism	0.000905	0.0042	CcSEcCtD
Pethidine—ALB—liver—hypothyroidism	0.00089	0.00817	CbGeAlD
Pethidine—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.000862	0.00429	CbGpPWpGaD
Pethidine—GRIN2D—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00086	0.00428	CbGpPWpGaD
Pethidine—Dizziness—Liotrix—hypothyroidism	0.000846	0.00393	CcSEcCtD
Pethidine—GRIN2A—Neuronal System—SLC5A7—hypothyroidism	0.00084	0.00418	CbGpPWpGaD
Pethidine—CYP2B6—gonad—hypothyroidism	0.000823	0.00756	CbGeAlD
Pethidine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00082	0.00408	CbGpPWpGaD
Pethidine—Vomiting—Liotrix—hypothyroidism	0.000814	0.00378	CcSEcCtD
Pethidine—OPRK1—Peptide GPCRs—TSHR—hypothyroidism	0.00081	0.00403	CbGpPWpGaD
Pethidine—Rash—Liotrix—hypothyroidism	0.000807	0.00375	CcSEcCtD
Pethidine—Dermatitis—Liotrix—hypothyroidism	0.000806	0.00374	CcSEcCtD
Pethidine—SLC6A2—testis—hypothyroidism	0.000805	0.0074	CbGeAlD
Pethidine—Headache—Liotrix—hypothyroidism	0.000802	0.00372	CcSEcCtD
Pethidine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000799	0.00398	CbGpPWpGaD
Pethidine—SLC6A2—NRF2 pathway—SLC5A7—hypothyroidism	0.000793	0.00395	CbGpPWpGaD
Pethidine—Nausea—Liotrix—hypothyroidism	0.00076	0.00353	CcSEcCtD
Pethidine—GRIN1—Neuronal System—SLC5A7—hypothyroidism	0.000733	0.00365	CbGpPWpGaD
Pethidine—CYP2B6—adrenal gland—hypothyroidism	0.000718	0.00659	CbGeAlD
Pethidine—CYP2B6—blood—hypothyroidism	0.000717	0.00659	CbGeAlD
Pethidine—CYP2C19—liver—hypothyroidism	0.000717	0.00658	CbGeAlD
Pethidine—GRIN2B—Neuronal System—SLC5A7—hypothyroidism	0.000714	0.00355	CbGpPWpGaD
Pethidine—GRIN2C—Neuronal System—NEFL—hypothyroidism	0.000709	0.00353	CbGpPWpGaD
Pethidine—GRIN2A—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000707	0.00351	CbGpPWpGaD
Pethidine—SLC6A3—NRF2 pathway—SLC5A7—hypothyroidism	0.000703	0.0035	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000692	0.00344	CbGpPWpGaD
Pethidine—OPRM1—Peptide GPCRs—TSHR—hypothyroidism	0.000685	0.00341	CbGpPWpGaD
Pethidine—GRIN2D—Neuronal System—NEFL—hypothyroidism	0.000659	0.00328	CbGpPWpGaD
Pethidine—GRIN1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000616	0.00307	CbGpPWpGaD
Pethidine—OPRM1—G-protein activation—POMC—hypothyroidism	0.000601	0.00299	CbGpPWpGaD
Pethidine—GRIN2B—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000601	0.00299	CbGpPWpGaD
Pethidine—CYP2B6—testis—hypothyroidism	0.000593	0.00545	CbGeAlD
Pethidine—SLC6A4—Circadian rythm related genes—NKX2-1—hypothyroidism	0.000592	0.00294	CbGpPWpGaD
Pethidine—GRIN1—EPH-Ephrin signaling—VAV3—hypothyroidism	0.000571	0.00284	CbGpPWpGaD
Pethidine—CYP2B6—liver—hypothyroidism	0.000561	0.00515	CbGeAlD
Pethidine—GRIN2B—EPH-Ephrin signaling—VAV3—hypothyroidism	0.000557	0.00277	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000546	0.00272	CbGpPWpGaD
Pethidine—CYP3A4—blood—hypothyroidism	0.000542	0.00498	CbGeAlD
Pethidine—GRIN2A—Neuronal System—NEFL—hypothyroidism	0.000541	0.00269	CbGpPWpGaD
Pethidine—CYP2D6—blood—hypothyroidism	0.000533	0.0049	CbGeAlD
Pethidine—OPRM1—TCR Signaling Pathway—SH2B3—hypothyroidism	0.000522	0.0026	CbGpPWpGaD
Pethidine—SLC6A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.0005	0.00249	CbGpPWpGaD
Pethidine—CYP2D6—female gonad—hypothyroidism	0.000497	0.00457	CbGeAlD
Pethidine—GRIN1—Neuronal System—NEFL—hypothyroidism	0.000472	0.00235	CbGpPWpGaD
Pethidine—GRIN2B—Neuronal System—NEFL—hypothyroidism	0.00046	0.00229	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—CLTC—hypothyroidism	0.000451	0.00224	CbGpPWpGaD
Pethidine—SLC6A3—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000443	0.0022	CbGpPWpGaD
Pethidine—CYP2D6—testis—hypothyroidism	0.000441	0.00405	CbGeAlD
Pethidine—GRIN2B—Axon guidance—CLTC—hypothyroidism	0.000439	0.00219	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.000428	0.00213	CbGpPWpGaD
Pethidine—CYP3A4—liver—hypothyroidism	0.000424	0.00389	CbGeAlD
Pethidine—SLC6A3—Neuronal System—SLC5A7—hypothyroidism	0.000419	0.00208	CbGpPWpGaD
Pethidine—CYP2D6—liver—hypothyroidism	0.000417	0.00383	CbGeAlD
Pethidine—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000414	0.00206	CbGpPWpGaD
Pethidine—CYP2D6—cerebellum—hypothyroidism	0.000407	0.00374	CbGeAlD
Pethidine—GRIN1—BDNF signaling pathway—VAV3—hypothyroidism	0.000406	0.00202	CbGpPWpGaD
Pethidine—GRIN2B—BDNF signaling pathway—VAV3—hypothyroidism	0.000396	0.00197	CbGpPWpGaD
Pethidine—SLC6A4—NRF2 pathway—SLC5A5—hypothyroidism	0.000369	0.00183	CbGpPWpGaD
Pethidine—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000368	0.00183	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000367	0.00183	CbGpPWpGaD
Pethidine—SLC6A3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000367	0.00183	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.000361	0.0018	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—VAV3—hypothyroidism	0.000358	0.00178	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000352	0.00175	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—CLTC—hypothyroidism	0.000322	0.0016	CbGpPWpGaD
Pethidine—SLC6A2—NRF2 pathway—SLC5A5—hypothyroidism	0.000317	0.00158	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—CLTC—hypothyroidism	0.000313	0.00156	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000287	0.00143	CbGpPWpGaD
Pethidine—SLC6A3—NRF2 pathway—SLC5A5—hypothyroidism	0.000281	0.0014	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000275	0.00137	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—NEFL—hypothyroidism	0.00027	0.00134	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000256	0.00127	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000256	0.00127	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000254	0.00126	CbGpPWpGaD
Pethidine—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000251	0.00125	CbGpPWpGaD
Pethidine—OPRM1—Opioid Signalling—POMC—hypothyroidism	0.00025	0.00124	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000242	0.00121	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000225	0.00112	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—AVP—hypothyroidism	0.000225	0.00112	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000225	0.00112	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—TRH—hypothyroidism	0.000218	0.00109	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000216	0.00107	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000216	0.00107	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—VAV3—hypothyroidism	0.000212	0.00106	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000211	0.00105	CbGpPWpGaD
Pethidine—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000208	0.00104	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—VAV3—hypothyroidism	0.000207	0.00103	CbGpPWpGaD
Pethidine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000202	0.001	CbGpPWpGaD
Pethidine—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.0002	0.000994	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—TSHB—hypothyroidism	0.000195	0.000968	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—TSHR—hypothyroidism	0.000195	0.000968	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.00019	0.000944	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000187	0.000928	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—TRH—hypothyroidism	0.000185	0.000918	CbGpPWpGaD
Pethidine—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000177	0.000881	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—TSHB—hypothyroidism	0.000165	0.000818	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—TSHR—hypothyroidism	0.000165	0.000818	CbGpPWpGaD
Pethidine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000164	0.000814	CbGpPWpGaD
Pethidine—SLC6A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000157	0.000783	CbGpPWpGaD
Pethidine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000152	0.000758	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—VAV3—hypothyroidism	0.000152	0.000754	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000151	0.000749	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000149	0.000743	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—VAV3—hypothyroidism	0.000148	0.000735	CbGpPWpGaD
Pethidine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00014	0.000698	CbGpPWpGaD
Pethidine—SLC6A3—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000139	0.000693	CbGpPWpGaD
Pethidine—ALB—Platelet degranulation—IGF1—hypothyroidism	0.00013	0.000646	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000128	0.000635	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000127	0.000633	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000126	0.000628	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—POMC—hypothyroidism	0.000126	0.000626	CbGpPWpGaD
Pethidine—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	0.000124	0.000615	CbGpPWpGaD
Pethidine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000124	0.000615	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—TRH—hypothyroidism	0.000123	0.000614	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—AVP—hypothyroidism	0.000115	0.000571	CbGpPWpGaD
Pethidine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000114	0.000566	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—TRH—hypothyroidism	0.000112	0.000558	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—TSHB—hypothyroidism	0.00011	0.000547	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—TSHR—hypothyroidism	0.00011	0.000547	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—POMC—hypothyroidism	0.000106	0.000529	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000106	0.000526	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—TRH—hypothyroidism	0.000104	0.000519	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—IYD—hypothyroidism	0.000103	0.00051	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000102	0.000505	CbGpPWpGaD
Pethidine—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.0001	0.0005	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.0001	0.000498	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—TSHR—hypothyroidism	9.99e-05	0.000497	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—TSHB—hypothyroidism	9.99e-05	0.000497	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—AVP—hypothyroidism	9.7e-05	0.000482	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—TRH—hypothyroidism	9.47e-05	0.000471	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	9.35e-05	0.000465	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—TSHB—hypothyroidism	9.3e-05	0.000463	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—TSHR—hypothyroidism	9.3e-05	0.000463	CbGpPWpGaD
Pethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	9.17e-05	0.000456	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	9e-05	0.000448	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ATP5O—hypothyroidism	8.72e-05	0.000434	CbGpPWpGaD
Pethidine—CYP2B6—Biological oxidations—POMC—hypothyroidism	8.69e-05	0.000432	CbGpPWpGaD
Pethidine—ALB—Metabolism—IYD—hypothyroidism	8.63e-05	0.000429	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.46e-05	0.000421	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—TSHR—hypothyroidism	8.44e-05	0.00042	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—TSHB—hypothyroidism	8.44e-05	0.00042	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—TPO—hypothyroidism	8.19e-05	0.000408	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—AVP—hypothyroidism	8e-05	0.000398	CbGpPWpGaD
Pethidine—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	7.91e-05	0.000393	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—IYD—hypothyroidism	7.75e-05	0.000385	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CLTC—hypothyroidism	7.66e-05	0.000381	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—POMC—hypothyroidism	7.62e-05	0.000379	CbGpPWpGaD
Pethidine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.43e-05	0.00037	CbGpPWpGaD
Pethidine—ALB—Metabolism—ATP5O—hypothyroidism	7.34e-05	0.000365	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—IYD—hypothyroidism	7.12e-05	0.000354	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—AVP—hypothyroidism	7.08e-05	0.000352	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SH2B3—hypothyroidism	7.02e-05	0.000349	CbGpPWpGaD
Pethidine—ALB—Metabolism—TPO—hypothyroidism	6.9e-05	0.000343	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—VAV3—hypothyroidism	6.73e-05	0.000335	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TRH—hypothyroidism	6.62e-05	0.000329	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ATP5O—hypothyroidism	6.59e-05	0.000328	CbGpPWpGaD
Pethidine—CYP2C19—Biological oxidations—POMC—hypothyroidism	6.57e-05	0.000327	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AVP—hypothyroidism	6.48e-05	0.000323	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CLTC—hypothyroidism	6.47e-05	0.000322	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—POMC—hypothyroidism	6.44e-05	0.000321	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.39e-05	0.000318	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TPO—hypothyroidism	6.19e-05	0.000308	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—VAV3—hypothyroidism	6.11e-05	0.000304	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ATP5O—hypothyroidism	6.06e-05	0.000301	CbGpPWpGaD
Pethidine—CYP2D6—Biological oxidations—POMC—hypothyroidism	6.04e-05	0.0003	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TSHB—hypothyroidism	5.9e-05	0.000294	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TSHR—hypothyroidism	5.9e-05	0.000294	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AVP—hypothyroidism	5.89e-05	0.000293	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	5.76e-05	0.000286	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.74e-05	0.000285	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TPO—hypothyroidism	5.7e-05	0.000283	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—VAV3—hypothyroidism	5.69e-05	0.000283	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TRH—hypothyroidism	5.6e-05	0.000278	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AVP—hypothyroidism	5.48e-05	0.000273	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SH2B3—hypothyroidism	5.26e-05	0.000262	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—VAV3—hypothyroidism	5.16e-05	0.000257	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.1e-05	0.000254	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TSHR—hypothyroidism	4.99e-05	0.000248	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TSHB—hypothyroidism	4.99e-05	0.000248	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AVP—hypothyroidism	4.98e-05	0.000248	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VAV3—hypothyroidism	4.82e-05	0.00024	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—IYD—hypothyroidism	4.66e-05	0.000232	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SH2B3—hypothyroidism	4.45e-05	0.000221	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—POMC—hypothyroidism	4.31e-05	0.000214	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	4.02e-05	0.0002	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ATP5O—hypothyroidism	3.96e-05	0.000197	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—POMC—hypothyroidism	3.95e-05	0.000196	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—POMC—hypothyroidism	3.91e-05	0.000195	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PRL—hypothyroidism	3.9e-05	0.000194	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—TSHB—hypothyroidism	3.79e-05	0.000189	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TPO—hypothyroidism	3.72e-05	0.000185	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—POMC—hypothyroidism	3.64e-05	0.000181	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VAV3—hypothyroidism	3.61e-05	0.00018	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AVP—hypothyroidism	3.48e-05	0.000173	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3C2A—hypothyroidism	3.38e-05	0.000168	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—POMC—hypothyroidism	3.31e-05	0.000165	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PRL—hypothyroidism	3.3e-05	0.000164	CbGpPWpGaD
Pethidine—ALB—Metabolism—TSHB—hypothyroidism	3.19e-05	0.000159	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VAV3—hypothyroidism	3.05e-05	0.000152	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IGF1—hypothyroidism	2.97e-05	0.000148	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AVP—hypothyroidism	2.94e-05	0.000146	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TSHB—hypothyroidism	2.87e-05	0.000143	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3C2A—hypothyroidism	2.85e-05	0.000142	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—SLC5A5—hypothyroidism	2.84e-05	0.000141	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.81e-05	0.00014	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TSHB—hypothyroidism	2.64e-05	0.000131	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	2.56e-05	0.000127	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.52e-05	0.000125	CbGpPWpGaD
Pethidine—ALB—Metabolism—SLC5A5—hypothyroidism	2.39e-05	0.000119	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	2.35e-05	0.000117	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—POMC—hypothyroidism	2.31e-05	0.000115	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IGF1—hypothyroidism	2.22e-05	0.000111	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SLC5A5—hypothyroidism	2.15e-05	0.000107	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC5A5—hypothyroidism	1.97e-05	9.82e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—POMC—hypothyroidism	1.95e-05	9.72e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF1—hypothyroidism	1.88e-05	9.35e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TSHB—hypothyroidism	1.72e-05	8.58e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.54e-05	7.64e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—POMC—hypothyroidism	1.49e-05	7.39e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.29e-05	6.42e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—POMC—hypothyroidism	1.25e-05	6.22e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—POMC—hypothyroidism	1.12e-05	5.59e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—POMC—hypothyroidism	1.03e-05	5.14e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—POMC—hypothyroidism	6.75e-06	3.36e-05	CbGpPWpGaD
